InvestorsObserver
×
News Home

Is CytoDyn Inc (CYDY) a Laggard in the Healthcare Sector?

Wednesday, May 11, 2022 10:44 AM | InvestorsObserver Analysts

Mentioned in this article

Is CytoDyn Inc (CYDY) a Laggard in the Healthcare Sector?

CytoDyn Inc (CYDY) is near the bottom in its sector according to InvestorsObserver. CYDY gets an overall rating of 19. That means it scores higher than 19% of stocks. CytoDyn Inc gets a 5 rank in the Healthcare sector. Healthcare is number 7 out of 11 sectors.

Overall Score - 19
CYDY has an Overall Score of 19. Find out what this means to you and get the rest of the rankings on CYDY!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With CytoDyn Inc Stock Today?

CytoDyn Inc (CYDY) stock is lower by -5.79% while the S&P 500 has gained 0.69% as of 10:29 AM on Wednesday, May 11. CYDY is down -$0.02 from the previous closing price of $0.36 on volume of 428,922 shares. Over the past year the S&P 500 is down -2.98% while CYDY is down -87.55%. CYDY lost -$0.23 per share the over the last 12 months. Click Here to get the full Stock Report for CytoDyn Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App